Dr Reddy's Laboratories Ltd (BSP:R1DY34)
R$ 81.66 0 (0%) Market Cap: 81.62 Bil Enterprise Value: 77.42 Bil PE Ratio: 19.94 PB Ratio: 3.76 GF Score: 85/100

Dr Reddy's Laboratories Ltd to Discuss Acquisition of Nicotinell Call Transcript

Jun 26, 2024 / 01:30PM GMT
Release Date Price: R$64
Operator

Ladies and gentlemen, good day and welcome to the conference call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Richa Periwal. Thank you, and over to you mam.

Richa Periwal;s Laboratories Limited;IR Executive
Dr. Reddy

'-

Thank you, [Summer]. A Good morning and good evening to all of you and thank you for joining us at such short notice. Earlier today, we have entered into a definitive agreement with Haley on plc to acquire Nickelodeon and related portfolio to discuss the acquisition, we have the leadership team of Dr. Reddy's comprising Mr. Erez Israeli, our CEO, Mr. Patrick Aghanian, our Head of Europe generics business. Mr. Parag Agarwal our CFO and the entire Investor Relations team. This call is being recorded and the playback and transcript shall be made available on our website soon.

Please note that today's call is a copyrighted material of Dr. Reddy's and cannot be rebroadcasted or attributed in press or media outlet without the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot